AGENT FOR TREATING infectious hepatitis, INCLUDING HEPATITIS C

摘要

1. a u0434u043bu00a0 u043bu0435u0447u0435u043du0438u00a0 infectious hepatitis, including hepatitis c virus, containing one or a mixture of several complex esters of - u0444u0442u0430u043bu0435u0432u043eu0439 acid normal or iso code u0440u043eu0435u043du0438u00a0 common formula;where n equals the number of 2 to 10.;2. a 1, u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0, mainly using esters of normal or u0438u0437u043eu0441u0442u0440u043eu0435u043du0438u00a0 u0444u0442u0430u043bu0435u0432u043eu0439 acid with the number of carbon atoms in the u0440u0430u0434u0438u043au0430u043bu0435 from 2 to 6.;3. a 1, u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 because it contains excipients.;4. a 1 or 3, u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0, as auxiliary substances used in pharmaceutical industry u0441u0432u00a0u0437u0443u044eu0449u0438u0435 inert pharmaceutical u043fu0440u0438u043du00a0u0442u044bu0435 genetic additive such as starch, intolerant, and others.;5. a 1 or 3, u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 because it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a capsule u0434u043bu00a0 oral u043fu0440u0438u043cu0435u043du0435u043du0438u00a0.;6. a 1 or 3, u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 because it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a u0442u0430u0431u043bu0435u0442u0438u0440u043eu0432u0430u043du043du0443u044e form.;7. a 1 or 3, u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 because it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a granules.;8. a u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 1, so that additionally contains the grass u0441u043eu043bu00a0u043du043au0438 u0445u043eu043bu043cu043eu0432u043eu0439 Salsola collina pall, u043fu043eu0434u0432u0435u0440u0433u043du0443u0442u0443u044e cut to a particle size less than 500 microns.;9. a u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 p.8, however, that it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a capsule u0434u043bu00a0 oral u043fu0440u0438u043cu0435u043du0435u043du0438u00a0.;10. a u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 p.8, however, that it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a u0442u0430u0431u043bu0435u0442u0438u0440u043eu0432u0430u043du043du0443u044e form.;11. a u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 p.8, however, that it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a granules.;12. a u043eu0442u043bu0438u0447u0430u044eu0449u0435u0435u0441u00a0 1, so that it u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a solution of liquid food, such as olive, and / or pharmacopoeia oils, for example u043au0430u0441u0442u043eu0440u043eu0432u043eu043c, u0447u0430u0443u043bu044c u043cu0443u0433u0440u043eu0432u043eu043c.